Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter-January 2024-www.financetom.com

Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter

Sep 24, 2025 5:28 AM

Sept 24 (Reuters) - Miner Freeport-McMoRan said

on Wednesday that it was expecting consolidated sales to be

about 4% lower for copper and nearly 6% lower for gold in the

third quarter, compared with its prior forecast.

(Reporting by Pooja Menon in Bengaluru; Editing by Anil

D'Silva)

Previous page： Spice maker McCormick beats quarterly results on strong EMEA business Next page： Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Spice maker McCormick beats quarterly results on strong EMEA business

Jun 27, 2024

(Reuters) - McCormick ( MKC ) beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out, improving volumes across the company's consumer segment, its biggest unit. Consumer sales in Europe, Middle East and...

Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month

Jun 27, 2024

June 27 (Reuters) - Verona Pharma's therapy for treating a chronic lung disease will be sold in the U.S. at a wholesale price of $2,950 per month, the U.K.-based company said on a conference call on Thursday. The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, provides a new inhaled non-steroidal treatment for chronic obstructive pulmonary...

Andlauer Healthcare to Launch Normal Course Issuer Bid

Jun 27, 2024

09:00 AM EDT, 06/27/2024 (MT Newswires) -- Andlauer Healthcare Group ( ANDHF ) said Thursday that it secured TSX approval for a normal course issuer bid (NCIB) for up to 10% of its public float over the next 12 months. The company said it can purchase its shares for cancellation beginning on July 2 and until July 1, 2025. Andlauer...

BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle

Jun 27, 2024

June 27 (Reuters) - Benson Hill Inc ( BHIL ): * ARGONAUTIC VENTURES - PRELIMINARY NON-BINDING PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION BY TO-BE-FORMED ACQUISITION VEHICLE * ARGONAUTIC VENTURES-PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION ALL OF OUTSTANDING SHARES FOR CASH CONSIDERATION OF $0.2236/SHARE Source text for Eikon: Further company coverage: ...